Phytoestrogens: Recent developments

Planta Medica

Volumn 69, Issue 7, 2003, Pages 589-599

  Cos, Paul ^a   De Bruyne, Tess ^a   Apers, Sandra ^a   Vanden Berghe, Dirk ^a   Pieters, Luc ^a   Vlietinck, Arnold J ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Estrogen receptor; Hop; Isoflavones; Lignans; Phytoestrogens; Resveratrol

Indexed keywords

BIOCHANIN A; COUMESTROL; DAIDZEIN; DAIDZIN; DIETHYLSTILBESTROL; ENTERODIOL; ENTEROLACTONE; EQUOL; ESTRADIOL; ESTROGEN RECEPTOR; FLAVONOID; FORMONONETIN; FULVESTRANT; GENISTEIN; IPRIFLAVONE; ISOFLAVONE; ISOFLAVONOID; LIGNAN; MATAIRESINOL; NARINGENIN; PHYTOESTROGEN; POLYPHENOL; RALOXIFENE; RESVERATROL; SECOISOLARICIRESINOL; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOYBEAN PROTEIN; STILBENE DERIVATIVE; TAMOXIFEN; UNINDEXED DRUG;

ARTIFICIAL MILK; BIOTRANSFORMATION; BREAST CANCER; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; CLINICAL TRIAL; DIETARY INTAKE; ESTROGEN ACTIVITY; ESTROGEN THERAPY; HEART PROTECTION; HUMAN; INFERTILITY; NONHUMAN; OSTEOPOROSIS; POSTMENOPAUSE; PROSTATE CANCER; REVIEW; SIDE EFFECT;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DIET; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, NON-STEROIDAL; HUMANS; ISOFLAVONES; PHYTOESTROGENS; PLANT PREPARATIONS;

GLYCINE MAX; HUMULUS;

EID: 0041379661     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41122     Document Type: Review

References (120)

1. Bennetts HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Australian Veterinary Journal 1946; 22: 2-12
2. Adams NR. Detection of the effects of phytoestrogens on sheep and cattle. J. Animal Sci 1995; 73: 1509-15
3. Baird D, Umbach D. Dietary intervention study to assess estrogenicity of dietary soy, among postmenopausal women. Clin Endocr 1995; 80: 1685-90
4. Denis L, Morton MS, Griffiths K. Diet and its preventive role in prostatic disease. Eur Urol 1999; 35: 377-87
5. Lee HP, Gourley L, Duffy SW. Dietary effects on breast-cancer risk in Singapore. Lancet 1991; 337: 1197-200
6. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998; 68: 1375S-9S
7. Bakhit RM, Klein BP, Essex-Sorlie D. Intake of 25 g of soybean protein with or without soybean fibre alters plasma lipids in men with elevated cholesterol concentrations. J Nutr 1994; 124: 213-22
8. Abe T. Infantile leukaemia and soybeans: a hypothesis. Leukaemia 1999; 13: 317-20
9. Diel P, Smolnikar K, Michna H. In vitro test systems for the evaluation of the estrogenic activity of natural products. Planta Med 1999; 65: 197-203
10. Murkies AL, Wilcox G, Davis SR. Phytoestrogens. J Clin Endocr Metab 1998; 83: 297-303
11. Wuttke W, Jarry H, Westphalen S, Christoffel V, Gorkow C, Seidlova-Wuttke D. Phytoestrogens: an alternative to standard hormone replacement therapy? Gynäkologe 2002; 35: 1007-20
12. King A, Young G. Characteristics and occurrence of phenolic phytochemicals. J Am Diet Assoc 1999; 99: 213-8
13. Reinli K, Block G. Phytoestrogen content of foods. Nutr Cancer 1996; 26: 123-48
14. Wang H, Murphy PA. Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop year and location. J Agr Food Chem 1994; 42: 1674-7
15. Wang H, Murphy PA. Isoflavone content in commercial soybean foods. J Agr Food Chem 1994; 42: 1666-73
16. Anderson RL, Wolf WJ. Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. J Nutr 1995; 206: 575S-86S
17. Fukutake M, Takahashi M, Ishida K, Kawamura H, Sugimura T, Wakabayashi K. Quantification of genistein and genistin in soybeans and soybean products. Food Chem Toxicol 1996; 34: 457-61
18. Coward L, Smith M, Kirk M, Barnes S. Chemical modification of isoflavones in soyfoods during cooking and processing. J Nutr 1998; 68: 1486S-91S
19. Day AJ, Dupont MS, Ridley S, Rhodes M, Rhodes MJC, Morgan MRA, Williamson G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity. FEBS Lett 1998; 436: 71-5
20. Hur HG, Rafii F. Biotransformation of the isoflavonoids biochanin A, formononetin, and glycitein by Eubacterium limosum. FEMS Microbiol Lett 2000; 192: 21-5
21. Kelly GE, Joannou GE, Reeder AY, Nelson C, Waring MA. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med 1995; 208: 40-3
22. Heinonen S, Wähälä K, Adlercreutz H. Identification of isoflavone metabolites dihydrodaidzein, dihydrogenistein, 6′-OH-O-DMA, and cis-4-OH-equol in human urine by gas chromatography-mass spectroscopy using authentic reference compounds. Anal Biochem 1999; 274: 211-9
23. Coldham NG, Darby C, Hows M, King LJ, Zhang AQ, Sauer MJ. Comparative metabolism of genistein by human and rat gut microflora: detection and identification of the end-products of metabolism. Xenobiotica 2002; 32: 45-62
24. Oitate M, Nakaki R, Koyabu N, Takanaga H, Matsuo H, Ohtani H, Sawada Y. Transcellular transport of genistein, a soybean-derived isoflavone, across human colon carcinoma cell line (Caco-2). Biopharm Drug Dispos 2001; 22: 23-9
25. Murota K, Shimizu S, Miyamoto S, Izumi T, Obata A, Kikuchi M, Terao J. Unique uptake and transport of isoflavone aglycones by human intestinal caco-2 cells: comparison of isoflavonoids and flavonoids. J Nutr 2002; 132: 1956-61
26. Walle UK, French KL, Walgren RA, Walle T. Transport of genistein-7-glucoside by human intestinal caco-2 cells: potential role for MRP2. Res Commun Mol Pathol Pharmacol 1999; 103: 45-56
27. Andlauer W, Kolb J, Fürst P. Isoflavones from tofu are absorbed and metabolized in the isolated rat small intestine. J Nutr 2000; 130: 3021-7
28. Andlauer W, Kolb J, Stehle P, Fürst P. Absorption and metabolism of genistein in isolated rat small intestine. J Nutr 2000; 130: 843-6
29. Setchell KDR, Brown NM, Zimmer-Nechemias L, Brashear WT, Wolfe BE, Kirschner AS, Heubi JE. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 2002; 76: 447-53
30. Lampe JW, Martini MC, Kurzer MS, Adlercreutz H, Slavin JL. Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr 1994; 60: 122-8
31. Davis SR, Dalais FS, Simpson ER, Murkies AL. Phytoestrogens in health and disease. Recent Prog Horm Res 1999; 54: 185-211
32. Price KR, Fenwick GR. Naturally-occurring estrogens in foods: a review. Food Addit Comtam 1985; 2: 73-106
33. Stevens JF, Ivancic M, Hsu VL, Deinzer ML. Prenylflavonoids from Humulus lupulus. Phytochemistry 1997; 44: 1575-85
34. Stevens JF, Taylor AW, Deinzer ML. Quantitative analysis of xanthohumol and related flavonoids in hops and beer by liquid chromatography-tandem mass spectrometry. J Chromatogr A 1999; 832: 97-107
35. Milligan SR, Kalita JC, Heyerick A, Rong H, De Cooman L, De Keukeleire D. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J Clin Endocr Metab 1999; 83: 2249-52
36. Milligan SR, Kalita JC, Pocock V, Van de Kauter V, Stevens JF, Deinzer ML et al. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J Clin Endocr Metab 2000; 85: 4912-5
37. Gester S, Metz P, Zierau O, Vollmer G. An efficient synthesis of the potent phytoestrogens 8-prenylnaringenin and 6-(1,1-dimethylallyl)-naringenin by europium(III)-catalyzed Claisen rearrangement. Tetrahedron 2001; 57: 1015-8
38. Langcake P, Pryce RJ. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection and injury. Physiol Plant Pathol 1976; 9: 77-86
39. Frémont L. Biological effects of resveratrol. Life Sci 2000; 66: 663-73
40. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? And gone? Clin Biochem 1997; 30: 91-113
41. Andlauer W, Kolb J, Siebert K, Furst P. Assessment of resveratrol bioavailability in the perfused small intestine of the rat. Drug Exp Clin Res 2000; 26: 47-55
42. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 2002; 302: 369-73
43. Soleas GJ, Yan J, Goldberg DM. Ultrasensitive assay for three polyphenols (catechin, quercetin, and resveratrol) and their conjugates in biological fluids utilizing gas chromatography with mass selective detection. J Chromatogr B 2001; 757: 161-72
44. Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer 1991; 16: 43-52
45. Borriello SP, Setchell KDR, Axelson M, Lawson AM. Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 1985; 58: 37-43
46. Adlercreutz H, Fotsis T, Kurzer MS, Wähälä K, Mäkelä T, Hase T. Isotope dilution gas chromatographic-mass spectrometric method for the determination of unconjugated lignans and isoflavonoids in human feces, with preliminary results in omnivorous and vegetarian women. Anal Biochem 1995; 225: 101-8
47. Morton MS, Chan PS, Cheng C, Blacklock N, Matos-Ferreira A, Abranches-Monteiro Let al. et alLignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate 1997; 32: 122-8
48. Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001; 276: 36869-72
49. Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. New Engl J Med 1992; 326: 852-6
50. McDonnell DP. The molecular pharmacology of SERMs. TEM 1999; 10: 301-11
51. Tikkanen MJ, Adlercreutz H. Dietary soy-derived isoflavone phytoestrogens: could they have a role in coronary heart disease prevention? Biochem Pharmacol 2000; 60: 1-5
52. Mitlak BH, Cohen FJ. Selective estrogen receptor modulators: a look ahead. Drugs 1999; 57: 653-63
53. Kuiper G, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93: 5925-30
54. Mosselman S, Polman J, Dijkema R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996; 392: 49-53
55. Dechering K, Boersma C, Mosselman S. Estrogen receptors α and β: two receptors of a kind? Curr Med Chem 2000; 7: 561-76
56. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997; 138: 863-70
57. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G et al. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997; 82: 4258-65
58. Branham WS, Dial SL, Moland CL, Hass BS, Blair RM, Fang H et al. Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. J Nutr 2002; 132: 658-64
59. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-63
60. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T et al. Interaction of phytoestrogens with estrogen receptors α and β. Biol Pharm Bull 2001; 24: 351-6
61. Morito K, Aomori T, Hirose T, Kinjo J, Hasegawa J, Ogawa S et al. Interaction of phytoestrogens with estrogen receptors α and β (II). Biol Pharm Bull 2002; 25: 48-52
62. Schmitt E, Dekant W, Stopper H. Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues. Toxicol in vitro 2001; 15: 433-9
63. Diel P, Olff S, Schmidt S, Michna H. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7. Planta Med 2001; 67: 510-4
64. Evans BA, Griffiths K, Morton MS. Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995; 147: 295-302
65. Mäkelä S, Poutanen M, Kostian ML, Lehtimaki N, Strauss L, Santti R, Vihko R. Inhibition of 17β-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc Soc Exp Biol Med 1998; 217: 310-6
66. Adlercreutz H, Bannwart C, Wahala KT. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 1993; 44: 147-53
67. Mousavi Y, Adlercreutz H. Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 1993; 58: 301-4
68. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N et al. Genistein, a specific inhibitor of tyrosine-specific protein kinase. J Biol Chem 1987; 262: 5592-5
69. Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. Effect of genistein on topoisomerase activity and on the growth of [Val12]Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 1988; 157: 183-9
70. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L. Genistein, a dietary derived inhibitor of angiogenesis. Proc Natl Acad Sci USA 1993; 90: 2690-4
71. Cos P, Calomme M, Sindambiwe JB, De Bruyne T, Cimanga K, Pieters L et al. Cytotoxicity and lipid peroxidation-inhibiting activity of flavonoids. Planta Med 2001; 67: 515-9
72. Strauss L, Santii R, Saarinen N, Streng T, Joshi S, Mäkelä S. Dietary phytoestrogens and their role in hormonally dependent disease. Toxicol Lett 1998; 102-103: 349-54
73. Kitaoka M, Kadokawa H, Sugano M, Ichikawa K, Taki M, Takaishi S et al. Prenylflavonoids: A new class of non-steroidal phytoestrogens (part 1). Isolation of 8-isopentenylnaringenin and an initial study on its structure-activity relationship. Planta Med 1998; 64: 511-5
74. Zierau O, Gester S, Schwab P, Metz P, Kolba S, Wulf M, Vollmer G. Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin. Planta Med 2002; 68: 449-51
75. Rong H, Boterberg T, Maubach J, Stove C, Depypere H, Van Slambrouck S et al. 8-Prenylnaringenin, the phytoestrogen in hops and beer, up-regulates the function of the E-cadherin/catenin complex in human mammary carcinoma cells. Eur J Cell Biol 2001; 80: 580-5
76. Miranda CL, Stevens JF, Ivanov V, McCall M, Frei B, Deinzer ML, Buhler DR. Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem 2000; 48: 3876-84
77. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β. Endocrinology 2000; 141: 3657-67
78. Basly JP, Marre-Fournier F, Le Bail JC, Habrioux G, Chulia AJ. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. Life Sci 2000; 66: 769-77
79. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 1997; 94: 14138-43
80. Lu RQ, Serrero G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol 1999; 179: 297-304
81. Bhat KPL, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 2001; 61: 7456-63
82. Turner RT, Evans GL, Zhang M, Maran A, Sibonga JD. Is resveratrol an estrogen agonist in growing rats?. Endocrinology 1999; 140: 50-4
83. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995; 235: 207-14
84. Goldberg DM, Hahn S, Parkes JG. Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta 1995; 237: 155-87
85. Tadolini B, Juliano C, Piu L, Franconi F, Cabrini L. Resveratrol inhibition of lipid peroxidation. Free Rad Res 2000; 33: 105-14
86. Pervaiz S. Resveratrol - from the bottle to the bedside? Leukemia Lymphoma 2001; 40: 491-8
87. Hsieh TC, Juan G, Darzynkiewicz Z, Wu JM. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21 (WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res 1999; 59: 2596-601
88. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles county. Brit J Cancer 1991; 63: 963-6
89. Messina M, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994; 21: 113-31
90. Stark A, Madar Z. Phytoestrogens: a review of recent findings. J Pediatr Endocr Met 2002; 15: 561-72
91. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol, 2002; 3: 364-73
92. Wu AH, Wan P, Hankin J, Tseng CO, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002; 23: 1491-6
93. Shu XO, Jin F, Dai Q, Wen WQ, Potter JD, Kushi LH et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidem Biomar 2001; 10: 483-8
94. Lamartiniere CA. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 2000; 71: 1705S-7S
95. Hulten K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G. An incident case-referent study on plasma enterolactone and breast cancer risk. Eur J Nutr 2002; 41: 168-76
96. Jacobsen BK, Knutsen SF, Fraser GE. Does high soy milk intake reduces prostate cancer incidence? The adventist health study (United States). Cancer Cause Control 1998; 9: 553-7
97. Nagata C, Inaba S, Kawakami N, Nakizoe T, Shimizu H. Inverse association of soy product intake with serum androgen and estrogen concentrations in Japanese men. Nutr Cancer 2000; 36: 14-8
98. Bingham SA, Atkinson C, Liggins J, Bluck L, Coward A. Phyto-oestrogens: where are we now? Brit J Nutr 1998; 79: 393-406
99. Messina M, Bennink M. Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data. Bailliere Clin Endocrinol Met 1998; 12: 707-28
100. Gardner CD, Newell KA, Cherin R, Haskell WL. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr 2001; 73: 728-35
101. Crouse JR, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 1999; 159: 2070-6
102. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 2001; 86: 3053-60
103. Glazier MG, Bowman M. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 2001; 161: 1161-72
104. Hodgson JM, Puddey IB, Beilin LJ, Mori TA, Croft KD. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr 1998; 128: 728-32
105. Simons LA, von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 2000; 85: 1297-301
106. Erdman JW. Soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation 2000; 102: 2555-9
107. Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 1998; 128: 954-9
108. Agnusdei D, Crepaldi G, Isaia G, Mazzuoli G, Ortolani S, Passed M, Bufalino L et al. A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss. Calcif Tissue Int 1997; 61: 142-7
109. Scheiber MD, Rebar RW. Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy? Menopause 1999; 6: 233-41
110. Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, Gennari C, Reginster JY. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA 2001; 285: 1482-8
111. Petilli M, Fiorelli G, Benvenuti S, Frediani U, Gori F, Brandi ML. Interactions between ipriflavone and the estrogen receptor. Calcif Tissue Int 1995; 56: 160-5
112. Lucas EA, Wild RD, Hammond LJ, Khalil DA, Juma S, Daggy BP, Stoecker BJ, Arjmandi BH. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 2002; 87: 1527-32
113. Potter SM, Baum JA, Teng HY, Stillman RJ, Shay NF, Erdman JW. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998; 68: 1375S-9S
114. Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery ML, Moreton T. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 2001; 8: 259-65
115. Scambia G, Mango D, Signorile PG, Angeli RA, Palena C, Gallo D et al. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 2000; 7: 105-11
116. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998; 91: 6-11
117. Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a north central cancer treatment group trial. J Clin Oncol 2000; 18: 1068-74
118. Duncan AM, Underhill KEW, Xu X, Lavalleur J, Phipps WR, Kurzer MS. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 1999; 84: 3479-84
119. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phyto-oestrogens from soy based infant formula. Lancet 1997; 350: 23-7
120. Yellay S, Naaz A, Szewczykowski MA, Sato T, Woods JA, Chang J et al. The phytoestrogen genistein induces thymic and immune changes: a human health concern? PNAS 2002; 99: 7616-21